Pxt3003 side effects. PXT3003 diminishes the abnormal growth of schwann cells if i know. com The potential approval of Pxt3003 could have a considerable global impact, particularly for patients suffering from neurological conditions such as CMT. The study also aims to assess the safety and tolerability (whether side effects of a medication can be handled by patients) of PXT3003. Potential Side Effects As with any medication, Pxt3003 may have potential side effects that need to be carefully evaluated. Aug 19, 2022 ยท Its duplication leads to abnormal levels of PMP22 protein, which then leads to a failure in the production of normal myelin. Patient Education The FDA approval of Pxt3003 opens avenues for patient education and awareness about the drug. - Q: Are there any side effects associated with Pxt3003? A: Common side effects of Pxt3003 include nausea, dizziness, and fatigue. Most were mild or moderate in severity. The FDA does not want to pass it if it does nothing, but the bar is about as low as it can be for getting a drug passed: a drug which is a combination of known drugs, minimal side effects, and offered as a treatment for a condition which has no current treatment. We are enrolling male and non-pregnant female subjects, aged 16 to 65 years with a genetically proven diagnosis of CMT1A. r2sh3 oyky9h axbrh 5guf5q uzo7iej p4dvgwb agzb yifsm iuc0 3lz9